Hansa Biopharma AB (HNSBF)
2.90
0.00 (0.00%)
USD |
OTCM |
Feb 26, 16:00
Hansa Biopharma Total Assets (Quarterly) : 126.56M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Orexo AB | -- |
| BioInvent International AB | 83.55M |
| BioArctic AB | 279.35M |
| BioGaia AB | 173.32M |
| Camurus AB | 514.16M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 135.69M |
| Shareholders Equity (Quarterly) | -9.126M |
| Debt to Equity Ratio | -11.10 |
| Current Ratio | 1.940 |
| Net Debt Paydown Yield | -0.46% |